Certified by Founder Lodge
Bicara Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $108,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The compa
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2023 | Series B | $108,000,000 | |
| December, 14 ,2023 | Series C | $165,000,000.00 |
Eight Roads
F-Prime Capital
The Invus Group
Omega Funds
RA Capital Management, L.P.
Piper Sandler
Janus Henderson Investors
Acorn Bioventures
Bioqube Ventures
Red Tree Venture Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
